ImmunityBio, Inc. IBRX

Maybe we get some big news pre market Monday

Reversing Lymphopenia will be the largest market for Anktiva because so many things cause it including old age. So you have an elderly patient with low ALC and they are fighting an infection hello Anktiva to the rescue. All cancer patients are potential uses. Septic patients on and on no other med crosses over like that to so many uses.

LR

why partner and share the profits and complicate decision making. It's like being self employed vs an employee get it

I am up 1.3 million thought I would be up 10 million by now. My bet $100 stock in 5 years maybe $300 in 10 years

Well up .26 for the week
.26x52=13.52 for the year if average .26 a week that works. Do it for 5 years and IBRX is a $70-$75 stock :)

640000x75=48,000,000 I am wealthy

I am long 640,000 shares and been in for a few years now huge in for over 1 year tired of waiting and ImmunityBio being ignored blackballed by the POS MSM

Share price down never makes logical sense to me with the multiple phase 1 2 and 3 trials ImmunityBio has going and a FDA approval a pending one

Paul Silberberg your thoughts please

Wow down so buy buy Buy BUY BUY

Let's add at least .60 today and close over $9 and start the run to $15-$20 and higher by the end of 2027